SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin gains after its healthcare business enters into partnership with Uttarakhand Police

24 Mar 2021 Evaluate

Lupin is currently trading at Rs. 1019.50, up by 4.45 points or 0.44% from its previous closing of Rs. 1015.05 on the BSE.

The scrip opened at Rs. 1016.70 and has touched a high and low of Rs. 1024.90 and Rs. 1005.20 respectively. So far 41748 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1121.85 on 18-Sep-2020 and a 52 week low of Rs. 536.80 on 30-Mar-2020.

Last one week high and low of the scrip stood at Rs. 1027.45 and Rs. 978.05 respectively. The current market cap of the company is Rs. 46215.66 crore.

The promoters holding in the company stood at 46.88%, while Institutions and Non-Institutions held 40.05% and 12.79% respectively.

Lupin’s consumer healthcare business -- LupinLife has entered into partnership with Uttarakhand Police for Kumbh Mela 2021. During the Kumbh, LupinLife will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers deployed at strategic locations - parking spots, food centres, health centres and bathing areas - in Hardwar to keep them safe from COVID-19 and other infections.

LupinLife will also provide brochures to the tourists to ensure they have access to critical information. These include road traffic routes to and from adjoining cities, major bathing dates, demarcated parking spots, etc to help tourists navigate their way easily. The brochures will be distributed at major parking spots to the tourists entering Hardwar by car.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2377.90 -81.85 (-3.33%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×